Evaluating treatment response using DW-MRI and DCE-MRI in trastuzumab responsive and resistant HER2-overexpressing human breast cancer xenografts
Author:
Funder
National Institutes of Health
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference44 articles.
1. Her2-positive breast cancer: herceptin and beyond;Dean-Colomb;Eur J Cancer,2008
2. Understanding the mechanisms behind trastuzumab therapy for human epidermal growth factor receptor 2-positive breast cancer;Spector;J Clin Oncol,2009
3. Humanization of an anti-p185HER2 antibody for human cancer therapy;Carter;Proc Natl Acad Sci U S A,1992
4. HER2 therapy: molecular mechanisms of trastuzumab resistance;Nahta;Breast Cancer Res,2006
5. The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy;Ross;Stem Cells,1998
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Bioactive Pentacyclic Triterpenes Trigger Multiple Signalling Pathways for Selective Apoptosis Leading to Anticancer Efficacy: Recent Updates and Future Perspectives;Current Protein & Peptide Science;2023-12
2. Habitat Imaging of Tumors Enables High Confidence Sub-Regional Assessment of Response to Therapy;Cancers;2022-04-26
3. Modulation of the Tumor Microenvironment with Trastuzumab Enables Radiosensitization in HER2+ Breast Cancer;Cancers;2022-02-17
4. Quantitative DCE-MRI of the Breast;Advances in Magnetic Resonance Technology and Applications;2022
5. Quantitative magnetic resonance imaging and tumor forecasting of breast cancer patients in the community setting;Nature Protocols;2021-09-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3